Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 06 crawled time : 15:30 save search
12/6/2021 – RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81
Published: 2021-12-06 (Crawled : 15:30) - respirerx.com
RSPI | $0.0008 0.0% 600K
|
Manufacturing
|
| O: -21.57%
H: 32.5%
C: 31.67%
commercialization
RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
RSPI | $0.0008 0.0% 600K
|
Manufacturing
|
| O: -21.57%
H: 32.5%
C: 31.67%
commercialization
PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationInstitutional Review Board (IRB) approval has been obtained and clinical trial recruitment resumes
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
PDSB | $2.64 -8.97% -9.85% 880K
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
phase 2 trial approval cancer biotech iot
Bsense Announces Positive Topline Proof-of-Concept Preclinical Data that Supports the Development in Additional Sensory Hyperexcitability Related Disorders
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: 0.0%
sensor order preclinical positive topline pre-clinical
Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
YTEN | $0.252 -7.59% -8.21% 280K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
conference bioscience
Applied DNA Advances Cotton Genomics-based Methodology for Determination of Authenticity and Provenance
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: -3.25%
H: 0.0%
C: 0.0%
genomics genomic
Upadacitinib (RINVOQ®) Achieved Primary and Key Secondary Endpoints in First Phase 3 Induction Study in Patients with Crohn's Disease
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
disease phase 3
Rhythm Pharmaceuticals and RareStone Ltd. Announce Exclusive Licensing Agreement for the Development and Commercialization of IMCIVREE (setmelanotide) in China
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
RYTM A | $37.975 -0.35% -0.36% 600K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
commercialization china setmelanotide imcivree license
New Mesoblast Data Offers Hope for High-Risk Heart Patients
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
MESO | $5.19 1.57% 1.54% 230K
|
Health Technology
|
| O: 5.25%
H: 0.0%
C: 0.0%
heart risk
BioSig to Participate in the Benzinga All Access Event on December 14, 2021
Published: 2021-12-06 (Crawled : 15:30) - globenewswire.com
BSGM | $1.41 -8.44% -9.22% 200K
|
Health Technology
|
| O: -3.04%
H: 0.0%
C: 0.0%
Hub Group presented U.S. EPA SmartWay Excellence Award for the ninth time
Published: 2021-12-06 (Crawled : 15:30) - globenewswire.com
HUBG | $39.84 2.84% 2.76% 490K
|
Transportation
|
| O: 0.18%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.